Research Article
Parameters of Somatosensory Evoked Potentials in Patients with Primary Sjӧgren’s Syndrome: Preliminary Results
Table 3
SEP latency and amplitude in pSS patients and in the control group. These are significant where
value < 0.005 (Bonferroni adjustment).
| | SEP | Study group
| Control group
| value | | Value | Mean ± SD | Mean ± SD |
| | Latency (ms) | | | | | N9 | 10.26 ± 0.90 | 9.51 ± 0.91 | 0.009 | | P10 | 12.23 ± 1.13 | 11.05 ± 0.96 | 0.0002 | | N13 | 13.74 ± 1.20 | 12.80 ± 1.10 | 0.0054 | | P16 | 16.97 ± 1.30 | 15.95 ± 0.89 | 0.0014 | | N20 | 20.07 ± 1.37 | 19.06 ± 1.17 | 0.0136 | | P22 | 23.18 ± 1.77 | 21.90 ± 1.60 | 0.0050 | | TT (N20–N13) | 6.29 ± 1.22 | 6.26 ± 0.85 | 0.8507 | | Amplitude (μV) | | | | | N9/P10 | 2.76 ± 1.26 | 2.79 ± 2.10 | 0.673 | | N13/P16 | 1.53 ± 0.62 | 0.99 ± 0.44 | 0.0005 | | N20/P22 | 1.29 ± 0.74 | 0.81 ± 0.47 | 0.0030 |
|
|